Related Experiment Videos
From ANA to ENA: how to proceed?
J G M C Damoiseaux1, J W Cohen Tervaert
1Department of Clinical and Experimental Immunology, University Hospital Maastricht, P. Debeyelaan 25, 6229 HX Maastricht, The Netherlands. jdam@limm.azm.nl
Autoimmunity Reviews
|December 13, 2005
Summary
Positive anti-nuclear antibody (ANA) tests in autoimmune diseases require specific anti-ENA antibody testing for accurate diagnosis. New detection systems need large clinical evaluation for reliable interpretation by clinicians.
Area of Science:
- Immunology
- Clinical Chemistry
Background:
- Anti-nuclear antibodies (ANA) are key indicators of autoimmune connective tissue diseases.
- Identifying extractable nuclear antigen (ENA) specificity refines disease classification.
Purpose of the Study:
- To review logistic aspects of anti-ENA antibody testing.
- To address challenges in adopting new anti-ENA antibody detection systems.
- To foster consensus on standardized testing protocols.
Main Methods:
- Review of current literature on ANA and ENA antibody detection.
- Discussion of technical developments in immunoassays.
- Analysis of clinical validation requirements for new assays.
Main Results:
- A positive ANA test, based on titer and pattern, necessitates further anti-ENA antibody testing.
- New anti-ENA antibody detection systems require extensive multicenter clinical validation.
- Clinician awareness of assay methodology is crucial for accurate interpretation.
Conclusions:
- Standardized anti-ENA antibody testing is essential for diagnosing autoimmune diseases.
- Further research and validation are needed for novel detection methods.
- Clear reporting and clinician education will improve diagnostic accuracy.